Lenti-ErbB2 CAR (scFv-28ζ, C6-B1D2)-VP(VP-CAR-LC753)
The ready-to-use lentiviral particles of Lenti-ErbB2 CAR (scFv-28ζ, C6-B1D2)-VP is packaged using 3rd generation of lentiviral packaging system, in which the gene of CAR will be driven by a CMV promotor. The target gene of scFv (C6-B1D2)-CD28-CD3ζ packaged in lentiviral particles could be used for high efficency tranduction of T cells and stably integrated expression.
Type of Therapeutics
Chimeric Antigen Receptor
ErbB2 positive cancers
This gene encodes a member of the epidermal growth factor (EGF) receptor family of receptor tyrosine kinases. This protein has no ligand binding domain of its own and therefore cannot bind growth factors. However, it does bind tightly to other ligand-bound EGF receptor family members to form a heterodimer, stabilizing ligand binding and enhancing kinase-mediated activation of downstream signalling pathways, such as those involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase. Allelic variations at amino acid positions 654 and 655 of isoform a (positions 624 and 625 of isoform b) have been reported, with the most common allele, Ile654/Ile655, shown here. Amplification and/or overexpression of this gene has been reported in numerous cancers, including breast and ovarian tumors. Alternative splicing results in several additional transcript variants, some encoding different isoforms and others that have not been fully characterized.
Erb-B2 Receptor Tyrosine Kinase 2; V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2; Tyrosine Kinase-Type Cell Surface Receptor HER2; Neuro/Glioblastoma Derived Oncogene Homolog; Human Epidermal Growth Factor Receptor 2; Metastatic Lymph Node Gene 19 Protein; Proto-Oncogene C-ErbB-2; Proto-Oncogene Neu; EC 184.108.40.206; P185erbB2; MLN 19; HER2; NGL; NEU; V-Erb-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (Neuro/Glioblastoma Derived Oncogene Homolog);
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
||Anti-HER2 (N29) h(CD28-CD3ζ) CAR, pCDCAR1
||Anti-HER2 (C5) h(CD28-CD3ζ) CAR, pCDCAR1
||Anti-ErbB2 scFv h(CD28-41BB-CD3ζ) CARNK, pCDCAR1
||Anti-ErbB2 scFv h(CD28-OX40-CD3ζ) CART, pCDCAR1
||Anti-HER2 VHH h(CD28-OX40-CD3ζ) CAR, [T]
||Lenti-ErbB2 CAR (scFv-CD28-CD3ζ, C6.5) Viral Particle
||Anti-ErbB2 scFv h(41BB-CD3ζ) CART, pCDCAR1
||Anti-HER2 (v574) h(CD28-CD3ζ) CAR, pCDCAR1
||Lenti-ErbB2 CAR (scFv-CD28-CD3ζ, OTI5C4) Viral Particle
||Anti-HER2 VHH h(CD4-CD3ζ) CAR, [T]